Advertisement

Quality of Life

  • Bidhu K. Mohanti
Chapter

Abstract

Quality of life (QoL) assessment of cancer patients gives a direct and subjective experience of his/her health status. Head and neck cancer patients, more specifically those with laryngeal and hypopharyngeal cancers, can face several issues which impact their physical, social and psychological aspects of daily living. The disease and its treatments can profoundly affect the speech and swallowing functions.

As a patient-reported outcome, QoL is devoid of any physician bias and has the potential benefits to assess the functional aspects of daily living. It is observed in clinical trials that patients who show better scores on QoL assessments can gain with improved survival. Head and neck oncologists should utilise the QoL instruments in conjunction with survival and morbidity assessments in the clinical practice.

References

  1. 1.
    Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res. 1993;2:153–9.CrossRefGoogle Scholar
  2. 2.
    Singer S, Langedijk J, Yarom N. Assessing and improving quality of life in patients with head and neck cancer. ASCO Educ Book. 2013:e2301–e235.  https://doi.org/10.1200/EdBook_AM.2013.33.e230.CrossRefGoogle Scholar
  3. 3.
    Ojo B, Genden EM, Teng MS, Milbury K, Misiukiewicz KJ, Badr H. A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol. 2012;48:923–37.CrossRefGoogle Scholar
  4. 4.
    Bjordal K, Bottomley A. Making advances in quality of life studies in head and neck cancer. Int J Radiat Oncol Biol Phys. 2017;97:659–61.CrossRefGoogle Scholar
  5. 5.
    Ramírez MJ, Ferriol EE, Doménech FG, et al. Psychosocial adjustment in patient surgically treated for laryngeal cancer. Otolaryngol Head Neck Surg. 2003;129:92–7.CrossRefGoogle Scholar
  6. 6.
    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefGoogle Scholar
  7. 7.
    Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–9.CrossRefGoogle Scholar
  8. 8.
    Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, Hackl NA, Heading G. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol. 2011;22:2179–90.CrossRefGoogle Scholar
  9. 9.
    Bansal M, Mohanti BK, Shah N, Chaudhry R, Bahadur S, Shukla NK. Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Qual Life Res. 2004;13:481–8.CrossRefGoogle Scholar
  10. 10.
    Chawla S, Mohanti BK, Rakshak M, Saxena S, Rath GK, Bahadur S. Temporal assessment of quality of life of head and neck cancer patients receiving radical radiotherapy. Qual Life Res. 1999;8:73–8.CrossRefGoogle Scholar
  11. 11.
    Guibert M, Lepage B, Woisard V, Rives M, Serrano E, Vergez S. Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer. Eur Ann Otolaryngol Head Neck Dis. 2011;128:218–23.CrossRefGoogle Scholar
  12. 12.
    The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.CrossRefGoogle Scholar
  13. 13.
    Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88(13):890–9.CrossRefGoogle Scholar
  14. 14.
    Lefebvre JL, Ang KK, Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Head Neck. 2009;31:429–41.CrossRefGoogle Scholar
  15. 15.
    Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, Morrison WH, Lewin JS, El-Naggar AK, Ginsberg LE, Kocak-Uzel E, Ang KK, Fuller CD. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey. Cancer. 2015;121:1608–19.CrossRefGoogle Scholar
  16. 16.
    Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz M Jr, Wolf GT, Shaha AR, Hartl DM, Olofsson J, Langendijk JA, Rinaldo A, Ferlito A, International Head and Neck Scientific Group. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012;34:270–81.CrossRefGoogle Scholar
  17. 17.
    Guibert M, Lepage B, Woisard V, Rives M, Serrano E, Vergez S. Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:218–23.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Bidhu K. Mohanti
    • 1
  1. 1.Department of Radiation OncologyManipal HospitalNew DelhiIndia

Personalised recommendations